Pluristem and Tnuva Appoint Eyal Rosenthal as CEO of Cultured Meat Joint Venture
Pluristem Therapeutics and Tnuva Group have appointed Eyal Rosenthal as CEO of their new joint venture focused on developing and commercializing cultured meat. Rosenthal brings extensive experience in food tech and agritech, which is expected to drive the venture's growth. The joint venture leverages Pluristem's cell production technology and Tnuva's food industry expertise.
Topics: biotechnology cultured meat executive appointment food tech joint venture